Click here to get full coverage on A Look At Pulse Biosciences (PLSE) Valuation After Recent Share Price Momentum - simplywall.st

A Look At Pulse Biosciences (PLSE) Valuation After Recent Share Price Momentum  simplywall.st

A Look At Pulse Biosciences (PLSE) Valuation After Recent Share Price Momentum - simplywall.st

Click here to get full coverage on Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? - Yahoo Finance

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts?  Yahoo Finance

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck - Stock Titan

Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck  Stock Titan

Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck - Stock Titan

Click here to get full coverage on PLSE: Unprecedented AFib ablation outcomes and rapid workflow drive strong clinical and market momentum - TradingView

PLSE: Unprecedented AFib ablation outcomes and rapid workflow drive strong clinical and market momentum  TradingView

PLSE: Unprecedented AFib ablation outcomes and rapid workflow drive strong clinical and market momentum - TradingView

Click here to get full coverage on Understanding the Setup: (PLSE) and Scalable Risk - Stock Traders Daily

Understanding the Setup: (PLSE) and Scalable Risk  Stock Traders Daily

Understanding the Setup: (PLSE) and Scalable Risk - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences CCO Danahy sells $118k in PLSE stock By Investing.com - Investing.com Nigeria

Pulse Biosciences CCO Danahy sells $118k in PLSE stock By Investing.com  Investing.com Nigeria

Pulse Biosciences CCO Danahy sells $118k in PLSE stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Stock Passes Above 50 Day Moving Average - Should You Sell? - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Passes Above 50 Day Moving Average - Should You Sell?  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Passes Above 50 Day Moving Average - Should You Sell? - MarketBeat

Click here to get full coverage on Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Business Wire

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference  Business Wire

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Business Wire

Click here to get full coverage on Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed? - Sahm

Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed?  Sahm

Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed? - Sahm

Click here to get full coverage on Pulse Biosciences (PLSE) Price Target Increased by 27.66% to 30.60 - Nasdaq

Pulse Biosciences (PLSE) Price Target Increased by 27.66% to 30.60  Nasdaq

Pulse Biosciences (PLSE) Price Target Increased by 27.66% to 30.60 - Nasdaq

Click here to get full coverage on Thyroid experts review 15–22 month data on Pulse nPulse ablation - Stock Titan

Thyroid experts review 15–22 month data on Pulse nPulse ablation  Stock Titan

Thyroid experts review 15–22 month data on Pulse nPulse ablation - Stock Titan

Click here to get full coverage on Pulse Biosciences posts updated investor deck highlighting nPulse cardiac catheter and strengthened EP focus - TradingView

Pulse Biosciences posts updated investor deck highlighting nPulse cardiac catheter and strengthened EP focus  TradingView

Pulse Biosciences posts updated investor deck highlighting nPulse cardiac catheter and strengthened EP focus - TradingView

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates  Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute - Stock Titan

Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute  Stock Titan

Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute - Stock Titan

Click here to get full coverage on Pulse Biosciences Executive Sells 60,000 Shares - TradingView

Pulse Biosciences Executive Sells 60,000 Shares  TradingView

Pulse Biosciences Executive Sells 60,000 Shares - TradingView

Click here to get full coverage on We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance

We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate  Yahoo Finance

We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance

Click here to get full coverage on Is Pulse Biosciences (PLSE) Share Price Justified After Recent Volatility In Healthcare Sentiment - simplywall.st

Is Pulse Biosciences (PLSE) Share Price Justified After Recent Volatility In Healthcare Sentiment  simplywall.st

Is Pulse Biosciences (PLSE) Share Price Justified After Recent Volatility In Healthcare Sentiment - simplywall.st

Click here to get full coverage on PLSE: Advanced pivotal clinical programs in AF ablation with rising losses and modest initial revenue - TradingView

PLSE: Advanced pivotal clinical programs in AF ablation with rising losses and modest initial revenue  TradingView

PLSE: Advanced pivotal clinical programs in AF ablation with rising losses and modest initial revenue - TradingView

Click here to get full coverage on Pulse Biosciences Highlights nPulse Cardiac Ablation Progress - TipRanks

Pulse Biosciences Highlights nPulse Cardiac Ablation Progress  TipRanks

Pulse Biosciences Highlights nPulse Cardiac Ablation Progress - TipRanks

Click here to get full coverage on PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - Zacks Investment Research

PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data  Zacks Investment Research

PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - Zacks Investment Research

Click here to get full coverage on Heart procedure trial hits 100% success as FDA okays pivotal study - Stock Titan

Heart procedure trial hits 100% success as FDA okays pivotal study  Stock Titan

Heart procedure trial hits 100% success as FDA okays pivotal study - Stock Titan

Click here to get full coverage on With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently - Yahoo Finance

With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently  Yahoo Finance

With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed?  Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Click here to get full coverage on CCO of Pulse Biosciences (NASDAQ: PLSE) sells 60,000 shares - Stock Titan

CCO of Pulse Biosciences (NASDAQ: PLSE) sells 60,000 shares  Stock Titan

CCO of Pulse Biosciences (NASDAQ: PLSE) sells 60,000 shares - Stock Titan

Click here to get full coverage on Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ) - Seeking Alpha

Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ)  Seeking Alpha

Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ) - Seeking Alpha

Click here to get full coverage on A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge - simplywall.st

A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge  simplywall.st

A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge - simplywall.st

Click here to get full coverage on The Technical Signals Behind (PLSE) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (PLSE) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (PLSE) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Releases Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Releases Earnings Results, Beats Estimates By $0.06 EPS  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Releases Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Shares Gap Down to $22.02 on Feb 20 - GuruFocus

Pulse Biosciences Inc (PLSE) Shares Gap Down to $22.02 on Feb 20  GuruFocus

Pulse Biosciences Inc (PLSE) Shares Gap Down to $22.02 on Feb 20 - GuruFocus

Click here to get full coverage on PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial - Zacks Investment Research

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial  Zacks Investment Research

PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial - Zacks Investment Research

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 48.59% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 48.59% Potential Upside in the Healthcare Sector  DirectorsTalk Interviews

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 48.59% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Click here to get full coverage on Kevin Patrick Danahy Sells 5,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat

Kevin Patrick Danahy Sells 5,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock  MarketBeat

Kevin Patrick Danahy Sells 5,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.2% Following Insider Selling - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.2% Following Insider Selling  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.2% Following Insider Selling - MarketBeat

Click here to get full coverage on Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval - Quiver Quantitative

Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval  Quiver Quantitative

Pulse Biosciences Stock (PLSE) Opinions on FDA IDE Approval - Quiver Quantitative

Click here to get full coverage on Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference - Business Wire

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference  Business Wire

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference - Business Wire

Click here to get full coverage on Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis

Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst  Trefis

Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - PrimePublishers.com

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates  PrimePublishers.com

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - PrimePublishers.com

Click here to get full coverage on Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial  Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Click here to get full coverage on Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat

Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock  MarketBeat

Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat

Click here to get full coverage on How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance

How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh  Yahoo Finance

How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance

Click here to get full coverage on PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - Nasdaq

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor  Nasdaq

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - Nasdaq

Click here to get full coverage on Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily

Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones  Stock Traders Daily

Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q2 2025 Earnings Call Highlights: Navigating Increased Expenses ... - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) to Release Earnings on Thursday - MarketBeat

Pulse Biosciences (PLSE) to Release Earnings on Thursday  MarketBeat

Pulse Biosciences (PLSE) to Release Earnings on Thursday - MarketBeat

Click here to get full coverage on Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.5% - Here's What Happened - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.5% - Here's What Happened  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.5% - Here's What Happened - MarketBeat

Click here to get full coverage on Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript - Insider Monkey

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript  Insider Monkey

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen - TradingView

Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen  TradingView

Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen - TradingView

Click here to get full coverage on Pulse Biosciences to detail 2025 results in Feb. 19 investor call - Stock Titan

Pulse Biosciences to detail 2025 results in Feb. 19 investor call  Stock Titan

Pulse Biosciences to detail 2025 results in Feb. 19 investor call - Stock Titan

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Shares Down 6.5% - Here's Why - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 6.5% - Here's Why  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 6.5% - Here's Why - MarketBeat

Click here to get full coverage on AF heart study in 150 patients reports 96% success at 1 year - Stock Titan

AF heart study in 150 patients reports 96% success at 1 year  Stock Titan

AF heart study in 150 patients reports 96% success at 1 year - Stock Titan

Click here to get full coverage on PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - Yahoo Finance

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor  Yahoo Finance

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor - Yahoo Finance

Click here to get full coverage on FDA OKs trial of nanosecond heart ablation for atrial fibrillation - Stock Titan

FDA OKs trial of nanosecond heart ablation for atrial fibrillation  Stock Titan

FDA OKs trial of nanosecond heart ablation for atrial fibrillation - Stock Titan

Click here to get full coverage on Pulse Biosciences (Nasdaq: PLSE) gets FDA IDE nod for first thyroid cancer nPulse study - Stock Titan

Pulse Biosciences (Nasdaq: PLSE) gets FDA IDE nod for first thyroid cancer nPulse study  Stock Titan

Pulse Biosciences (Nasdaq: PLSE) gets FDA IDE nod for first thyroid cancer nPulse study - Stock Titan

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week High - What's Next? - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week High - What's Next?  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week High - What's Next? - MarketBeat

Click here to get full coverage on How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study  Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans  simplywall.st

Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Insider Kevin Patrick Danahy Sells 20,000 Shares - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Insider Kevin Patrick Danahy Sells 20,000 Shares  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Insider Kevin Patrick Danahy Sells 20,000 Shares - MarketBeat

Click here to get full coverage on A Glimpse of Pulse Biosciences's Earnings Potential - Benzinga

A Glimpse of Pulse Biosciences's Earnings Potential  Benzinga

A Glimpse of Pulse Biosciences's Earnings Potential - Benzinga

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Sees Strong Trading Volume - Should You Buy? - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Sees Strong Trading Volume - Should You Buy?  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Sees Strong Trading Volume - Should You Buy? - MarketBeat

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's What Happened - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's What Happened  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Here's What Happened - MarketBeat

Click here to get full coverage on 150-patient AF study puts nanosecond heart ablation tech in Boston spotlight - Stock Titan

150-patient AF study puts nanosecond heart ablation tech in Boston spotlight  Stock Titan

150-patient AF study puts nanosecond heart ablation tech in Boston spotlight - Stock Titan

Click here to get full coverage on Pulse Biosciences To Offer Securities Worth $200 Million - TradingView

Pulse Biosciences To Offer Securities Worth $200 Million  TradingView

Pulse Biosciences To Offer Securities Worth $200 Million - TradingView

Click here to get full coverage on Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛

Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30  富途牛牛

Mizuho Securities Maintains Pulse Biosciences(PLSE.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛

Click here to get full coverage on PLSE Stock Today: December 29 – JPM Healthcare Conference Slot Announced - Meyka

PLSE Stock Today: December 29 – JPM Healthcare Conference Slot Announced  Meyka

PLSE Stock Today: December 29 – JPM Healthcare Conference Slot Announced - Meyka

Click here to get full coverage on Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView

Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results  TradingView

PLSE

Price Chart

Key Statistics

Technicals

About PLSE

Latest News

A Look At Pulse Biosciences (PLSE) Valuation After Recent Share Price Momentum - simplywall.st

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? - Yahoo Finance

Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck - Stock Titan

Advanced Charts

Top Gainers

Top Losers